A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

Clinical trial NCT05769075 · UNKNOWN

Trial details

NCT number: NCT05769075
Sponsor: TYK Medicines, Inc
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2023-04-20
Primary completion: 2025-01-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.